Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Ovarian Neoplasms 32Breast Neoplasms 25Fallopian Tube Neoplasms 21Multiple Myeloma 18Carcinoma, Ovarian Epithelial 14Lymphoma 8Triple Negative Breast Neoplasms 4Recurrence 3Neoplasms, Plasma Cell 3Hodgkin Disease 3Prostatic Neoplasms 2Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Large B-Cell, Diffuse 2Leukemia 2Hematologic Neoplasms 2Burkitt Lymphoma 2Subcutaneous panniculitis-like T-cell lymphoma 1Solid Tumors 1Sarcoma, Synovial 1Sarcoma, Kaposi 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Patient Participation 1Pancreatic Neoplasms 1Osteosarcoma 1Neurofibrosarcoma 1

Interventions

Valganciclovir 3Specimen Handling 3Magnetic Resonance Spectroscopy 3Biopsy 3Bevacizumab 3technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2Nivolumab 2tocilizumab 1pomalidomide 1pembrolizumab 1liposomal doxorubicin 1emvododstat 1efineptakin alfa 1cabozantinib 1Zidovudine 1Sunitinib 1Polymerase Chain Reaction 1Nelfinavir 1Maraviroc 1Lenalidomide 1Ipilimumab 1Immunohistochemistry 1Imatinib Mesylate 1HhAntag691 1Gene Expression Profiling 1Etoposide 1Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1CTLA-4 Antigen 1Antiretroviral Therapy, Highly Active 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Sarcoma, Kaposi × liposomal doxorubicin × Clear all
NCT00923936 2018-07-24

Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
16 enrolled 13 charts
Sarcoma

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡